[PDF] Top 20 “Acceso a los servicios de salud desde la percepción de las personas transgénero influencias en salud”

... of avelumab was conducted from a UK National Health Service ...tioned-survival model based on the JAVELIN Merkel 200 ...of avelumab resulted in an incremental cost-effectiveness ratio (ICER) ... See full document

... As of September 3, 2016 (data cutoff date), median follow-up was 16.4 months (range, 12.1-25.4). Treat- ment was ongoing in 19 patients (21.6%), and 69 pa- tients (78.4%) had discontinued treatment—mostly due to ... See full document

... extensive metastatic spread of the MCC, immune-checkpoint therapy with a PD-1 inhibitor was recommended by our interdisciplinary tumor ...life-threatening metastatic MCC with a response rate of around 60% ... See full document

... mUC patients to various available treatment ...the model. The BIM compared a scenario with the projected uptake of avelumab among other treat- ment options (world with avelumab: new scenario) ... See full document

... Abstract: Merkel cell carcinoma (MCC), a rare skin cancer, is associated with high mortal- ity, especially in a metastatic ...the patients have had early relapse without any effective ... See full document

... of avelumab in advanced MCC, it is not the end of cytotoxic chemotherapy in ...with metastatic disease, immunotherapy will likely leave chemotherapy as an option for those who are not candidates for or ... See full document

... of patients with metastatic clear-cell renal cell carcinoma (mccRCC) in daily ...practice. Patients and methods: All consecutive patients with histologically confirmed ... See full document

... Renal cell carcinoma (RCC) is the most common type of kidney malignancy, and the clear-cell subtype represents the majority of ...RCC patients has been observed due to new effective therapies, ... See full document

... Figure 2 Quantification of ganglion cell complex (GCC) using Fourier-domain optical coherence tomography (FD-OCT) in the case of severe glaucomatous ganglion cell loss. Three different colorimetric maps were ... See full document

... for metastatic pros- tate cancer ever since the work of Huggins and Hodges, which helped understand the hormone-sensitivity of pros- tate cancer ...both metastatic and N+ prostate cancer before it was ... See full document

... recurrent, metastatic MCC that involved several sites in liver, bones and disseminated ...the Merkel cell polyomavirus T-antigen oncoprotein was negative ...his metastatic MCC, the patient ... See full document

... of patients with RLN node metastasis was better in the three-field lymphadenectomy group than in the two-field lymphadenectomy group, while in patients without RLN node metastasis, there was no significant ... See full document

... Care Model on Blood Pressure and Quality of Life in Patients on ...Belief Model based nursing intervention on Chinese patients with moderate to severe chronic obstructive pulmonary disease: a ... See full document

... serous carcinoma, mucinous carcin- oma, endometrioid carcinoma and clear cell carcinoma), stage, therapy, recurrence free interval (if applicable), and site of recurrent disease (if ... See full document

... elderly patients were comparable with those younger patients, consistent with earlier ...old patients ( ≥ 80 years), Bensalah et al 9 reported a higher risk for impaired renal function after surgery, ... See full document

... between cell morphology and MCPyV positivity or copy ...MCPyV­positive cell lines were found to contain a premature stop codon resulting in the aforementioned truncated ... See full document

... Jones SD et al., reported a case of Lactobacillus pneumonia transmitted by transplanted lung [11]. Though only one case has been reported so for but it has greater significance in lung transplant patients. Both ... See full document

... We divided pretreatment neutrophil counts into two levels (high and low) depending on the cut-off values mentioned in studies. We integrated the pooled HRs and 95% CIs to estimate the effect of pretreatment neutrophil ... See full document

... was calculated from the date of surgery to the date of disease recurrence/progression. Patients who did not experience recurrence were ceased at the date of the last follow-up. The receiver operating ... See full document

... of avelumab in maintenance therapy is being evaluated in patients with advanced UC who have completed at least four cycles of platinum-based che- motherapy without evidence of disease progression (JAVELIN ... See full document